rs764742792
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000320005.6(CNGB3):c.1063C>T(p.Arg355Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000081 in 1,604,956 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R355R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000320005.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNGB3 | NM_019098.5 | c.1063C>T | p.Arg355Ter | stop_gained | 10/18 | ENST00000320005.6 | NP_061971.3 | |
CNGB3 | XM_011517138.3 | c.649C>T | p.Arg217Ter | stop_gained | 8/16 | XP_011515440.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNGB3 | ENST00000320005.6 | c.1063C>T | p.Arg355Ter | stop_gained | 10/18 | 1 | NM_019098.5 | ENSP00000316605 | P1 | |
CNGB3 | ENST00000681546.1 | n.883C>T | non_coding_transcript_exon_variant | 5/13 | ||||||
CNGB3 | ENST00000681746.1 | c.1063C>T | p.Arg355Ter | stop_gained, NMD_transcript_variant | 10/19 | ENSP00000505959 |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 150120Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250160Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135262
GnomAD4 exome AF: 0.00000756 AC: 11AN: 1454836Hom.: 0 Cov.: 31 AF XY: 0.00000967 AC XY: 7AN XY: 723908
GnomAD4 genome AF: 0.0000133 AC: 2AN: 150120Hom.: 0 Cov.: 31 AF XY: 0.0000137 AC XY: 1AN XY: 73224
ClinVar
Submissions by phenotype
Achromatopsia 3 Pathogenic:4
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Jun 16, 2017 | - - |
Pathogenic, no assertion criteria provided | research | Molecular Genetics Laboratory, Institute for Ophthalmic Research | Mar 27, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 02, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.002%). Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000427687). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Achromatopsia Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 14, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 08, 2023 | This sequence change creates a premature translational stop signal (p.Arg355*) in the CNGB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CNGB3 are known to be pathogenic (PMID: 28795510). This variant is present in population databases (rs764742792, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with Achromatopsia (PMID: 28795510). ClinVar contains an entry for this variant (Variation ID: 427687). For these reasons, this variant has been classified as Pathogenic. - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Ophthalmic Genetics Group, Institute of Molecular and Clinical Ophthalmology Basel | May 27, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at